My research is focused on understanding how the gut microbiome and body composition contribute to cardiometabolic health, especially in high-risk and underrepresented populations (e.g., African ancestry populations, health disparities, persons living with HIV), with the goal of informing microbially targeted interventions to reduce cardiometabolic risk. I have experience in epidemiologic research using international populations and populations across the lifecourse.